Fatigue in Sarcoidosis
|
|
- Doreen Hardy
- 7 years ago
- Views:
Transcription
1 Fatigue in Sarcoidosis Elyse E. Lower, M.D. Sarcoidosis & Interstitial Lung Disease Clinic University of Cincinnati Fatigue in Sarcoidosis Up to 80% of patients with sarcoidosis report fatigue Fatigued patients report worse Quality of Life Many sarcoidosis patients with good control of disease still have persistent, disabling fatigue
2 Ermüdung Vermoeidheid Fatiga 疲 労 Fatica замор Fatigue Yorgunluk 疲 勞, 勞 累 Yтомление épuisement What is Fatigue? Temporary loss of strength and energy Tiredness Exhaustion Lethargy Weariness
3 Fatigue: transient or selflimiting Viral or other infection Overwork Stress Sleep deprivation Jet-leg Listen to the signals of your body Take a nap on time Vincent van Gogh
4 What Causes Fatigue? Diabetes
5 Thyroid Disease Anemia
6 Impaired Mobility: Heart or Lung Disease, Arthritis Sleep Disorders
7 Poor Nutrition Recurrent Infections
8 Depression Assessment of Fatigue
9 Fatigue Intervention: Disease Control Treatment can be a double-edged sword. Sarcoid granulomas may worsen fatigue. However, treatment with corticosteroids may lead to side effects that worsen fatigue. Weight gain Diabetes Sleep apnea Assessment of Fatigue
10 Additional Fatigue Intervention Lifestyle changes Exercise Diet Weight reduction Persistent Fatigue: Sarcoidosis Associated Fatigue
11 Fatigue Assessment Instrument Pitfalls for Studying Fatigue Measuring fatigue is difficult Placebo effect is powerful Fatigue varies from person to person
12 Measuring Fatigue Multiple instruments to measure QOL and fatigue No perfect testing Chronic Illness FACIT-F, SF-36 WHO-QOL Sarcoidosis Fatigue Assessment Scale (FAS) Neurostimulant Therapy for Sarcoid Associated Fatigue Case reports suggest benefit for methylphenidate (Ritalin ) for chronic sarcoidosis patients with persistent fatigue. Other neurostimulants, including dexmethylphenidate (Focalin ), can improve fatigue in cancer patients with chemo brain.
13 A Phase II, Randomized Placebo-controlled Trial of the Safety and Efficacy of d-mph as a New Treatment of Fatigue and Chemobrain in Adult Cancer Patients E. Lower 1, S. Fleishman 2, A. Cooper 3, J. Zeldis 3, H. Faleck 3, D. Manning 3 1 University of Cincinnati Medical Center, Cincinnati, OH 2 Beth Israel Cancer Center, New York, NY 3 Celgene Corporation, Warren, NJ Lower EE, J Pain Symptom Manage 2009;38: Purpose of Study To evaluate the efficacy and safety of dexmethylphenidate (d-mph, Focalin ), a CNS stimulant, for the treatment of fatigue and cognitive impairment associated with chemotherapy
14 Change in FACIT-F (fatigue) Total Score at Each Week Treatment Week Change from Baseline * * p < 0.05 ** p < 0.01 * ** * ** * ** d-mph d-mph LOCF PLCBO PLCBO LOCF LOCF = Last observation carried forward A Randomized Double Blind, Placebo Controlled Trial of Dexmethylphenidate Hydrochloride (d-mph) for Sarcoidosis Associated Fatigue Elyse E. Lower, MD Stacy Harman Robert P. Baughman, MD University of Cincinnati Sarcoidosis Interstitial Lung Disease Clinic Lower EE, Harman S, Baughman RP. Chest 2008; 133:
15 Double Blind, Placebo-Controlled, Cross Over Study d-mph d-mph Washin Washout Treatment 1 Treatment 2 Placebo Placebo Week of Study Treatment 1: d-mph or Placebo Treatment 2: Placebo or d-mph (opposite of treatment 1) FAS: Lower Score, Less Fatigue Placebo d-mph FAS Score Baseline Weeks of Therapy Difference between d-mph and placebo p<0.02
16 FACIT-F: Higher Score, Less Fatigue Placebo d-mph FACIT-F Score Weeks of Therapy Difference between d-mph and placebo p<0.005 Sleep Disorders
17 Why do Neurostimulants Improve Fatigue? Sleep problems are common in patients with fatigue Methylphenidate is useful in treating excessive sleepiness or narcolepsy Armodafinil (Nuvigil ) is also useful in treating excessive daytime somnolence Assessed by Mean Sleep Latency Time (MSLT) Armodafinil for Sarcoidosis Associated Fatigue: Double Blind, Placebo Controlled, Cross Over Trial Elyse E Lower, M.D.1, Atul Malhotra, M.D.2, Victoria Surdulescu, M.D.1, Robert P. Baughman, M.D.1 1 University of Cincinnati 2 Cleveland Clinic Foundation Lower, E. E. et al. J.Pain Symptom.Manage e-published
18 R-Modafinil for Sarcoidosis Associated Fatigue Study Aims Determine if r-modafinil is effective in treating sarcoidosis associated fatigue Study design similar to d-mph study Determine if r-modafinil is more effective in treating sarcoidosis associated fatigue in patients with excessive daytime somnolence Determined by Mean Sleep Latency Time (MSLT) < 8 minutes Double Blind, Placebo-Controlled, Cross Over Study r-modafinil r-modafinil Washin Washout Treatment 1 Treatment 2 Sleep Study MSLT Placebo Sleep Study MSLT Placebo Week of Study Treatment 1: r-modafinil or Placebo Treatment 2: Placebo or r-modafinil (opposite of treatment 1)
19 ALL PATIENTS Change in FAS score from Baseline after 8 weeks of therapy, p<0.01 Change in FAS Score from Baseline Eight Weeks Therapy MSLT < 8 minutes 10 Eight Weeks Therapy MSLT > 8 minutes 20 Change FAS from Baseline Change FAS from Baseline Placebo Armodafinil Placebo Armodafinil Red: MSLT <8 minutes; Blue MSLT>8 minutes
20 Summary of r-modafinil Study r-modafinil was effective in treating sarcoidosis associated fatigue The drug was as effective for patients without hypersomnolence (MSLT>8 minutes) as for those with hypersomnolence (MSLT<8 minutes) Summary and Conclusions Fatigue is a very common problem in sarcoidosis Assessment needs to include Appropriate disease treatment Evaluation and treatment of other medical problems Persistent fatigue may require intervention with neurostimulants along with lifestyle changes
21 Thank you Questions? Assessment of Fatigue
Chemotherapy-associated fatigue and cognitive impairment: a proposed SWOG clinical trial. Patient A. Patient A
Chemotherapy-associated fatigue and cognitive impairment: a proposed SWOG clinical trial Helen K. Chew, MD, FACP Associate Professor of Internal Medicine University of California Davis Patient A A 59 y/o
More informationChemobrain. Halle C.F. Moore, MD The Cleveland Clinic October 3, 2015
Chemobrain Halle C.F. Moore, MD The Cleveland Clinic October 3, 2015 Terminology Chemotherapy-associated cognitive dysfunction Post-chemotherapy cognitive impairment Cancer treatment-associated cognitive
More informationNUVIGIL (armodafinil) oral tablet
NUVIGIL (armodafinil) oral tablet Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit plan. This Pharmacy Coverage
More information5.07.04. Provigil Nuvigil. Provigil (modafinil) / Nuvigil (armodafinil) Description. Section: Prescription Drugs Effective Date: July 1, 2015
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 5.07.04 Subject: Provigil Nuvigil Page: 1 of 6 Last Review Date: June 19, 2015 Provigil Nuvigil Description
More informationDEPRESSION Depression Assessment PHQ-9 Screening tool Depression treatment Treatment flow chart Medications Patient Resource
E-Resource March, 2015 DEPRESSION Depression Assessment PHQ-9 Screening tool Depression treatment Treatment flow chart Medications Patient Resource Depression affects approximately 20% of the general population
More informationGeneral Information about Sleep Studies and What to Expect
General Information about Sleep Studies and What to Expect Why do I need a sleep study? Your doctor has ordered a sleep study because your doctor is concerned you may have a sleep disorder that is impacting
More informationDepression in Older Persons
Depression in Older Persons How common is depression in later life? Depression affects more than 6.5 million of the 35 million Americans aged 65 or older. Most people in this stage of life with depression
More informationRiociguat Clinical Trial Program
Riociguat Clinical Trial Program Riociguat (BAY 63-2521) is an oral agent being investigated as a new approach to treat chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension
More informationOnce the immune system is triggered, cells migrate from the blood into the joints and produce substances that cause inflammation.
HealthExchange Points For Your Joints An Arthritis Talk Howard Epstein, MD Orthopaedic & Rheumatologic Institute Rheumatic & Immunologic Disease Cleveland Clinic Beachwood Family Health & Surgery Center
More informationPart 1: Depression Screening in Primary Care
Part 1: Depression Screening in Primary Care Toni Johnson, MD Kristen Palcisco, BA, MSN, APRN MetroHealth System Objectives Part 1: Improve ability to screen and diagnose Depression in Primary Care Increase
More informationDIAGRAM I: OVERVIEW CANCER REHABILITATION
DIAGRAM I: OVERVIEW CANCER REHABILITATION DETECTION AND REFERRAL TRIAGE & EVALUATION FOR CANCER REHABILITATION Interview plus distress thermometer: Emotional problems Fatigue Physical / functional problems
More informationLevel 1. Nutrition & Lifestyle Oncology Certificate
Level 1 Nutrition & Lifestyle Oncology Certificate ONE MODULE 1 A Cancer Diagnosis Learn what cancer is; how/why it develops; diagnostic tests; inflammatory/ hormonal connections; 5 most important steps
More informationStanford University s Chronic Disease Self-Management Program Curriculum and Evidence
Stanford University s Chronic Disease Self-Management Program Curriculum and Evidence What is the Chronic Disease Self-Management Program? The Chronic Disease Self-Management Program (CDSMP), developed
More informationNew Treatments for Stroke Prevention in Atrial Fibrillation. John C. Andrefsky, MD, FAHA NEOMED Internal Medicine Review course May 5 th, 2013
New Treatments for Stroke Prevention in Atrial Fibrillation John C. Andrefsky, MD, FAHA NEOMED Internal Medicine Review course May 5 th, 2013 Classification Paroxysmal atrial fibrillation (AF) Last < 7
More informationSeniors and. Depression. What You Need to Know. Behavioral Healthcare Options, Inc.
Seniors and Depression What You Need to Know Behavioral Healthcare Options, Inc. Depression More Than Just The Blues ou may not know exactly what is wrong with you, but you do know that you just don t
More informationWhat Causes Cancer-related Fatigue?
What Causes Cancer-related Fatigue? The causes of cancer-related fatigue are not fully understood. It may be the cancer and/or the cancer treatment. Cancer and cancer treatment can change normal protein
More informationAmino Acid Therapy to Restore Neurotransmitter Function
Amino Acid Therapy to Restore Neurotransmitter Function Alvin Stein, MD Neurotransmitters are chemicals manufactured by our bodies that allow our nervous system to function properly. When the body requires
More informationCancer-Related Brain Fog
Cancer-Related Brain Fog Information for Cancer Patients and Caregivers about Cancer-Related Brain Fog Princess Margaret Also called Chemo-Fog, Chemo-Brain, or Cancer-Related Cognitive Dysfunction Please
More informationSLEEP DISTURBANCE AND PSYCHIATRIC DISORDERS
E-Resource December, 2013 SLEEP DISTURBANCE AND PSYCHIATRIC DISORDERS Between 10-18% of adults in the general population and up to 50% of adults in the primary care setting have difficulty sleeping. Sleep
More informationTalking With Your Doctor About Multiple Myeloma: A guide to making the most of your healthcare visits
There s a lot to think about and many important decisions to make when you or someone you care for has multiple myeloma. It s important to have an ongoing conversation with your healthcare team throughout
More informationMS Fatigue an Overview
MS Fatigue an Overview Acknowledgement We acknowledge and pay respect to the traditional custodians past and present on whose lands we meet today. We acknowledge the deep feelings of attachment and the
More informationAt Centers for Integrative Medicine and Healing we have a 97% successful response rate to our Acupuncture and Integrative Medicine treatments.
Centers for Integrative Medicine and Healing (CIMH) is the nation s leading and most advanced Integrative Medicine and Acupuncture clinic. At CIMH we have one focus. That focus is building a better, healthier,
More informationLOW T NATION TESTOSTERONE INTAKE FORM NAME: DATE: ADDRESS: CITY: STATE: ZIP: CELL #: HOME #: SOC SECURITY #: DATE OF BIRTH:
LOW T NATION TESTOSTERONE INTAKE FORM NAME: DATE: ADDRESS: CITY: STATE: ZIP: CELL #: HOME #: SOC SECURITY #: DATE OF BIRTH: DRIVERS LICENSE NUMBER: STATE: EMAIL ADDRESS: MARITAL STATUS: ( ) SINGLE ( )
More informationPROTOCOL SYNOPSIS Evaluation of long-term opioid efficacy for chronic pain
P a g e 1 PROTOCOL SYNOPSIS Evaluation of long-term opioid efficacy for chronic pain Clinical Phase 4 Study Centers Study Period 25 U.S. sites identified and reviewed by the Steering Committee and Contract
More informationDon t just dream of higher-quality sleep. How health care should be
Don t just dream of higher-quality sleep. How health care should be Many of our patients with sleep disorders don t realize there s another way of life, a better way, until they are treated. Robert Israel,
More informationSARCOIDOSIS. Signs and symptoms associated with specific organ involvement can include the following:
SARCOIDOSIS Sarcoidosis is a disease that occurs when areas of inflammation develop in different organs of the body. Very small clusters of inflammation, called granulomas, are seen with sarcoidosis. They
More informationTITLE: Modafinil for Sleep Disorders and Fatigue Secondary to Multiple Sclerosis: A Review of the Clinical Efficacy and Safety
TITLE: Modafinil for Sleep Disorders and Fatigue Secondary to Multiple Sclerosis: A Review of the Clinical Efficacy and Safety DATE: 27 July 2012 CONTEXT AND POLICY ISSUES Modafinil is a central nervous
More informationA Healthy Life RETT SYNDROME AND SLEEP. Exercise. Sleep. Diet 1. WHY SLEEP? 4. ARE SLEEP PROBLEMS A COMMON PARENT COMPLAINT?
Diet Sleep Exercise RETT SYNDROME AND SLEEP DR. DANIEL GLAZE, MEDICAL DIRECTOR THE BLUE BIRD CIRCLE RETT CENTER A good night s sleep promotes learning, improved mood, general good health, and a better
More informationVersion History. Previous Versions. Drugs for MS.Drug facts box fingolimod Version 1.0 Author
Version History Policy Title Drugs for MS.Drug facts box fingolimod Version 1.0 Author West Midlands Commissioning Support Unit Publication Date Jan 2013 Review Date Supersedes/New (Further fields as required
More informationTreatment of Chronic Pain: Our Approach
Treatment of Chronic Pain: Our Approach Today s webinar was coordinated by the National Association of Community Health Centers, a partner with the SAMHSA-HRSA Center for Integrated Health Solutions SAMHSA
More informationNot All Clinical Trials Are Created Equal Understanding the Different Phases
Not All Clinical Trials Are Created Equal Understanding the Different Phases This chapter will help you understand the differences between the various clinical trial phases and how these differences impact
More informationCancer-Related Fatigue Facts
LEUKEMIA LYMPHOMA MYELOMA FACTS Cancer-Related Fatigue Facts No. 3 in a series providing the latest information for patients, caregivers and healthcare professionals. Highlights Estimates are that more
More informationNEURO-OPHTHALMIC QUESTIONNAIRE NAME: AGE: DATE OF EXAM: CHART #: (Office Use Only)
PAGE 1 NEURO-OPHTHALMIC QUESTIONNAIRE NAME: AGE: DATE OF EXAM: CHART #: (Office Use Only) 1. What is the main problem that you are having? (If additional space is required, please use the back of this
More informationCare Planning and Goal setting in Diabetes management
Care Planning and Goal setting in Diabetes management How can we provide self-management support to people with chronic conditions? Professor Malcolm Battersby Flinders University Flinders Human Behaviour
More informationSelf-management for people with chronic health conditions Innovation Community
Self-management for people with chronic health conditions Innovation Community Presenter Kate Lorig, DrPH Stanford Patient Education Research Center 1000 Welch Road, Suite 204 Palo Alto CA 94304 USA 650-723-7935
More informationYour Certified Professional Cancer Coach. An Integrative Answer to Cancer Exclusive Professional Program for Patients with Cancer
Your Certified Professional Cancer Coach An Integrative Answer to Cancer Exclusive Professional Program for Patients with Cancer The CPCC Patient Program Nutrition & Lifestyle Oncology A Cancer Diagnosis
More informationMS fatigue, as described
Marc Romanelli/Getty Images Taking Fatigue Seriously: New Focus on This MS Symptom First in a three-part article series MS fatigue, as described by one MS support group participant, is the feeling that
More informationTara Leigh Taylor, MD, FCCP Intensivist, Wyoming Medical Center
Tara Leigh Taylor, MD, FCCP Intensivist, Wyoming Medical Center Objectives Define the magnitude of the problem Define diagnostic criteria of insomnia Understand the risk factors and consequences of insomnia
More informationCOULD IT BE LOW TESTOSTERONE?
COULD IT BE LOW TESTOSTERONE? By Dr. Lauren M. Bramley For thousands of years women have been recognized for their sensitivity to hormones. PMS, post partum depression, menopause have long been plights
More informationDiagnosis and Treatment
Sleep Apnea: Diagnosis and Treatment Sleep Apnea Sleep Apnea is Common Dangerous Easily recognized Treatable Types of Sleep Disordered Breathing Apnea Cessation of airflow > 10 seconds Hypopnea Decreased
More informationCoping With Stress and Anxiety
Coping With Stress and Anxiety Stress and anxiety are the fight-and-flight instincts that are your body s way of responding to emergencies. An intruder crawling through your bedroom window in the dark
More informationDealing with Cognitive Impairment in the Patient with Breast Cancer
Dealing with Cognitive Impairment in the Patient with Breast Cancer Tim A. Ahles, Ph.D. Department of Psychiatry and Behavioral Sciences Neurocognitive Research Lab Sources of Funding Office of Cancer
More informationDENVER CHIROPRACTIC CENTER GLENN D. HYMAN, DC, CSCS
DENVER CHIROPRACTIC CENTER GLENN D. HYMAN, DC, CSCS Are you in the right place? Please read this before proceeding with paperwork: At Denver Chiropractic Center, we specialize in treating muscles with
More informationInsomnia affects 1 in 3 adults every year in the U.S. and Canada.
Insomnia What is insomnia? Having insomnia means you often have trouble falling or staying asleep or going back to sleep if you awaken. Insomnia can be either a short-term or a long-term problem. Insomnia
More informationObservational studies on homeopathy
Observational studies on homeopathy To healthcare providers, patients and clinicians, what matters most is not necessarily how well a treatment performs under the artificially controlled conditions on
More informationClinical bottom line. For more detailed evidence on the effectiveness of injections for tennis elbow, please see the CAT on:
Short Question: Specific Question: In patients presenting with acute or chronic tendinopathies, what is the incidence of harm for those receiving steroid injections compared to those receiving usual care?
More informationHow To Get A Dbs Therapy For Obsessive Compulsive Disorder
Sample Appeal Letters Appeals Payers who deny coverage usually do so for one of these three reasons: The therapy is investigational / experimental The therapy is not medically necessary The therapy is
More informationConsequences of Excessive Daytime Sleepiness
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/clinicians-roundtable/consequences-of-excessive-daytimesleepiness/1904/
More informationSupplements in Psychiatry: N-Acetylcysteine, Omega-3 Fatty Acids & Melatonin. March 19, 2004 David A. Graeber, MD UNM Department of Psychiatry
Supplements in Psychiatry: N-Acetylcysteine, Omega-3 Fatty Acids & Melatonin March 19, 2004 David A. Graeber, MD UNM Department of Psychiatry 1 N-Acetylcysteine = NAC NAC modulates Neurotransmitters: 1.
More informationReading: Skimming and Scanning
Reading: Skimming and Scanning Skimming involves quickly glancing through a text to get a general sense of what it is about. You do not actually read the whole piece; you simply look through it, perhaps
More informationRheumatoid Arthritis www.arthritis.org.nz
Rheumatoid Arthritis www.arthritis.org.nz Did you know? RA is the second most common form of arthritis Approximately 40,000 New Zealanders have RA RA can occur at any age, but most often appears between
More informationDMSRU Education Series 2012
DMSRU Education Series 2012 Why Am I So Tired?? Fatigue is one of the most commonly reported symptoms of MS Affects 70-90% of those living with MS and many report it as their most disabling symptom Experienced
More informationWhat You Need to Know About LEMTRADA (alemtuzumab) Treatment: A Patient Guide
For Patients What You Need to Know About LEMTRADA (alemtuzumab) Treatment: A Patient Guide Patients: Your doctor or nurse will go over this patient guide with you. It is important to ask any questions
More informationMANAGEMENT OF LIPID DISORDERS: IMPLICATIONS OF THE NEW GUIDELINES
MANAGEMENT OF LIPID DISORDERS: IMPLICATIONS OF THE NEW GUIDELINES Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine Declaration of full disclosure: No conflict of interest EXPLAINING
More informationMedical Information to Support the Decisions of TUECs INTRINSIC SLEEP DISORDERS
Introduction Excessive daytime sleepiness (EDS) is a common complaint. Causes of EDS are numerous and include: o Intrinsic sleep disorders (e.g. narcolepsy, obstructive sleep apnoea/hypopnea syndrome (OSAHS)
More informationPut Life Back In Your Life
Put Life Back In Your Life Many Faces of Community Health October 29, 2010 Pam Van Zyl York, MPH, PhD, RD, LN Minnesota Department of Health The Chronic Disease Self-Management Program Agenda Benefits,
More informationNew England Pain Management Consultants At New England Baptist Hospital
New England Pain Management Consultants At New England Baptist Hospital Pain Management Center Health Assessment Dear New Pain Management Patient, Welcome to the New England Pain Management Consultants
More informationSubcutaneous Testosterone-Anastrozole Therapy in Breast Cancer Survivors. 2010 ASCO Breast Cancer Symposium Abstract 221 Rebecca L. Glaser M.D.
Subcutaneous Testosterone-Anastrozole Therapy in Breast Cancer Survivors 2010 ASCO Breast Cancer Symposium Abstract 221 Rebecca L. Glaser M.D., FACS Learning Objectives After reading and reviewing this
More informationNew Treatments. For Bipolar Disorder. Po W. Wang, MD Clinical Associate Professor Bipolar Disorders Clinic Stanford University School of Medicine
New Treatments For Bipolar Disorder Po W. Wang, MD Clinical Associate Professor Bipolar Disorders Clinic Stanford University School of Medicine Abbott Laboratories AstraZeneca Bristol-Myers Squibb Corcept
More informationSee also www.thiswayup.org.au/clinic for an online treatment course.
Depression What is depression? Depression is one of the common human emotional states. It is common to experience feelings of sadness and tiredness in response to life events, such as losses or disappointments.
More informationLiver Disease & Hepatitis Program Providers: Brian McMahon, MD, Steve Livingston, MD, Lisa Townshend, ANP. Primary Care Provider:
Liver Disease & Hepatitis Program Providers: Brian McMahon, MD, Steve Livingston, MD, Lisa Townshend, ANP Primary Care Provider: If you are considering hepatitis C treatment, please read this treatment
More informationRibavirin/Pegylated Interferon Combination Therapy for People with Hepatitis C
Ribavirin/Pegylated Combination Therapy for People with Hepatitis C 1. Introduction 2. What the treatment does 3. When to take it 4. What is? 5. What is interferon? 6. What is pegylated interferon? 7.
More informationSponsor Novartis Pharmaceuticals
Clinical Trial Results Database Page 1 Sponsor Novartis Pharmaceuticals Generic Drug Name Indacaterol Therapeutic Area of Trial Chronic Obstructive Pulmonary Disease (COPD) Indication studied: COPD Study
More informationSevere asthma Definition, epidemiology and risk factors. Mina Gaga Athens Chest Hospital
Severe asthma Definition, epidemiology and risk factors Mina Gaga Athens Chest Hospital Difficult asthma Defined as asthma, poorly controlled in terms of chronic symptoms, with episodic exacerbations,
More informationCopywrite - Eric Freitag, Psy.D., 2012
Diagnosis, Intervention and Care for Patients With Cognitive Impairment Eric J. Freitag, Psy.D, FACPN Diplomate, American College of Professional Neuropsychology Mt. Diablo Memory Center Founder/Executive
More informationTreatment Options for ADHD in Children and Teens. A Review of Research for Parents and Caregivers
Treatment Options for ADHD in Children and Teens A Review of Research for Parents and Caregivers Is This Summary Right for Me? Yes, if: A doctor said that your child or teen has attention deficit hyperactivity
More informationSleep Disorders and Sleep Deprivation: An Unmet Public Health Problem
Sleep Disorders and Sleep Deprivation: An Unmet Public Health Problem Nearly 40 million Americans suffer from sleep disorders Greater in women National Sleep Foundation 2010 Sleep in America Poll 25% reported
More informationUnderwriting Sleep Apnea
Underwriting Sleep Apnea Joel Weiner, MD, FLMI April 29, 2014 WAHLU The Northwestern Mutual Life Insurance Company Milwaukee, WI A Brief Survey Before We Get Started The Weiner Sleepiness Scale How likely
More informationCorporate Presentation May 13, 2015
Corporate Presentation May 13, 2015 Creating the Next Generation of CNS Drugs Forward-Looking Statement This presentation contains forward-looking statements. These statements relate to future events and
More informationParkinson Disease Levodopa-Induced Dyskinesia. Christopher Kenney, MD Novartis Pharmaceuticals
Parkinson Disease Levodopa-Induced Dyskinesia Christopher Kenney, MD Novartis Pharmaceuticals Disclosures Dr. Kenney is a full-time employee of Novartis Pharmaceuticals Corporation The opinions expressed
More informationBetter Choices, Better Health
PROGRAM BROCHURE Fall 2015 and Winter 2016 October 2015 March 2016 Education Classes Better Choices, Better Health Exercise Classes D isease-specific and general topics are offered in different formats
More informationSUBSTANCE ABUSE & DEPRESSION: WHAT YOU SHOULD KNOW
SUBSTANCE ABUSE & DEPRESSION: WHAT YOU SHOULD KNOW TABLE OF CONTENTS What is Depression? 4 Symptoms of Depression 6 Substance Abuse as a Coping Mechanism 8 Which Occurs First? 10 Substance Abuse and the
More informationDepression and Mental Health:
Depression and Mental Health: A Psychiatrist s Perspective Peter M. Lake, MD Medical Director Rogers Memorial Hospital Oconomowoc Depression The Intersection of Hope, Medicine and Research Marquette University
More informationGetting Clinicians Involved: Testing Smartphone Applications to Promote Behavior Change in Health Care
Getting Clinicians Involved: Testing Smartphone Applications to Promote Behavior Change in Health Care Xiaomu Zhou 4 Huntington Street xmyzhou@rutgers.edu Lora Appel 4 Huntington Street lappel@eden.rutgers.edu
More informationSLEEP AND PARKINSON S DISEASE
A Practical Guide on SLEEP AND PARKINSON S DISEASE MICHAELJFOX.ORG Introduction Many people with Parkinson s disease (PD) have trouble falling asleep or staying asleep at night. Some sleep problems are
More informationA Depression Education Toolkit
A Depression Education Toolkit Facts about Depression in Older Adults What is Depression? Depression is a medical illness. When sadness persists or interferes with everyday life, it may be depression.
More informationDisease Modifying Therapies for MS
Disease Modifying Therapies for MS The term disease-modifying therapy means a drug that can modify or change the course of a disease. In other words a DMT should be able to reduce the number of attacks
More informationThe type of cancer Your specific treatment Your pre training levels before diagnose (your current strength and fitness levels)
Exercise and Breast Cancer: Things you can do! Cancer within the fire service is one of the most dangerous threats to our firefighter s health & wellness. According to the latest studies firefighters are
More informationIMPACT: An Evidence-based Approach to Integrated Depression Care Beth Israel Medical Center New York, NY. Day One: June 8, 2011
IMPACT: An Evidence-based Approach to Integrated Depression Care Beth Israel Medical Center New York, NY 8:00 Registration & Continental Breakfast 8:30 Welcome & Introductions Day One: June 8, 2011 8:45
More informationSleep Deprivation and Post-Treatment (CBD)
Population Authors & year Design Intervention (I) and Comparison (C) Mean age (SD) 1 Gender (%) Delivered to Dosage (total number of sessions) Primary Outcome domain (Measure(s)) Secondary Outcome domain
More informationParticipating in Alzheimer s Disease Clinical Trials and Studies
Participating in Alzheimer s Disease Clinical Trials and Studies FACT SHEET When Margaret was diagnosed with earlystage Alzheimer s disease at age 68, she wanted to do everything possible to combat the
More informationPATHWAYS TO TYPE 2 DIABETES. Vera Tsenkova, PhD Assistant Scientist Institute on Aging University of Wisconsin-Madison
PATHWAYS TO TYPE 2 DIABETES Vera Tsenkova, PhD Assistant Scientist Institute on Aging University of Wisconsin-Madison Overview Diabetes 101 How does diabetes work Types of diabetes Diabetes in numbers
More informationOlder Drivers Guide to Driving Safely
Fit to Drive Traffic Safety for Older Drivers Are you fit to drive? The aging process may increase your risk of being in a traffic crash, and it affects the severity of injuries you experience. Drivers
More informationDrugs for MS.Drug fact box cannabis extract (Sativex) Version 1.0 Author
Version History Policy Title Drugs for MS.Drug fact box cannabis extract (Sativex) Version 1.0 Author West Midlands Commissioning Support Unit Publication Date Jan 2013 Review Date Supersedes/New (Further
More informationWhich injectable medication should I take for relapsing-remitting multiple sclerosis?
Which injectable medication should I take for relapsing-remitting multiple sclerosis? A decision aid to discuss options with your doctor This decision aid is for you if you: Have multiple sclerosis Have
More informationSleep Difficulties. Insomnia. By Thomas Freedom, MD and Johan Samanta, MD
Sleep Difficulties By Thomas Freedom, MD and Johan Samanta, MD For most people, night is a time of rest and renewal; however, for many people with Parkinson s disease nighttime is a struggle to get the
More informationBRIEF NOTES ON THE MENTAL HEALTH OF CHILDREN AND ADOLESCENTS
BRIEF NOTES ON THE MENTAL HEALTH OF CHILDREN AND ADOLESCENTS The future of our country depends on the mental health and strength of our young people. However, many children have mental health problems
More informationHEALTH INSURANCE EMPLOYEE EDUCATION: PREVENTIVE CARE
HEALTH INSURANCE EMPLOYEE EDUCATION: PREVENTIVE CARE Mott Community College Health Benefits Task Force DISCLAIMER The content in this presentation is informational. Each employee should review the benefit
More informationEffective Care Management for Behavioral Health Integration
Effective Care Management for Behavioral Health Integration Title: Effective Care Management for Behavioral Health Integration A process improvement initiative focused on improving mental health outcomes
More informationRN Care Manager Assessment: The 4 Domains
RN Care Manager Assessment: The 4 Domains Access to Care Experience with Provider(s) Getting Needed Services Coordination of Care Medical Home / Services Risk Medical Neighborhood Social Support Home Environment
More informationDepression and its Treatment in Older Adults. Gregory A. Hinrichsen, Ph.D. Geropsychologist New York City
Depression and its Treatment in Older Adults Gregory A. Hinrichsen, Ph.D. Geropsychologist New York City What is Depression? Everyday use of the word Clinically significant depressive symptoms : more severe,
More informationAtrial Fibrillation (AF) March, 2013
Atrial Fibrillation (AF) March, 2013 This handout is meant to help with discussions about the condition, and it is not a complete discussion of AF. We hope it will complement your appointment with one
More informationJAMES PETROS, M.D., INC. PHONE: (408) 528-8833 FAX: (408) 528-8557
FIGHTING PAIN. TOUCHING LIVES. JAMES PETROS, M.D., INC. PHONE: (408) 528-8833 FAX: (408) 528-8557 Personal Information Emergency Contact Today s Date: Name: Patient: Realtionship: Birth Date: Age: Sex:
More informationMellen Center for Multiple Sclerosis
Mellen Center Cleveland Clinic Marie Namey, RN, MSN, MSCN Mellen Center Cleveland Clinic Cleveland, OH Home of. Mellen Center for Multiple Sclerosis Mellen Center Mission The Mellen Center remains committed
More information75-09.1-08-02. Program criteria. A social detoxi cation program must provide:
CHAPTER 75-09.1-08 SOCIAL DETOXIFICATION ASAM LEVEL III.2-D Section 75-09.1-08-01 De nitions 75-09.1-08-02 Program Criteria 75-09.1-08-03 Provider Criteria 75-09.1-08-04 Admission and Continued Stay Criteria
More informationSUBSTANCE USE DISORDER SOCIAL DETOXIFICATION SERVICES [ASAM LEVEL III.2-D]
SUBSTANCE USE DISORDER SOCIAL DETOXIFICATION SERVICES [ASAM LEVEL III.2-D] I. Definitions: Detoxification is the process of interrupting the momentum of compulsive drug and/or alcohol use in an individual
More informationCapacity to Care: Building Competency in Geriatric Mental Health Care Evidence Based Practices & Psychosocial Interventions
Capacity to Care: Building Competency in Geriatric Mental Health Care Evidence Based Practices & Psychosocial Interventions Nancy P. Kropf School of Social Work Georgia State University Define Evidence
More informationSnoring and Obstructive Sleep Apnea (updated 09/06)
Snoring and Obstructive Sleep Apnea (updated 09/06) 1. Define: apnea, hypopnea, RDI, obstructive sleep apnea, central sleep apnea and upper airway resistance syndrome. BG 2. What are the criteria for mild,
More informationHEADACHES IN CHILDREN AND ADOLESCENTS. Brian D. Ryals, M.D.
HEADACHES IN CHILDREN AND ADOLESCENTS Brian D. Ryals, M.D. Frequency and Type of Headaches in Schoolchildren 8993 children age 7-15 in Sweden Migraine in 4% Frequent Nonmigrainous in 7% Infrequent Nonmigrainous
More informationDrug Treatment for Weight Loss: New Advances
Drug Treatment for Weight Loss: New Advances William G. Haynes FRCP MD Professor of Internal Medicine Divisions of Endocrinology and Cardiovascular Medicine University of Iowa Outline Why should we use
More information